• Economy
  • Investing
  • Politics
  • Sports
  • Editor’s Pick
Market Gains Updates
Sports

Teammate: Skaggs informed him Angels staffer was source for opioids

by December 2, 2025
by December 2, 2025

After six weeks of testimony from the plaintiffs, the Los Angeles Angels began their defense in the wrongful death lawsuit brought by the family of deceased pitcher Tyler Skaggs by calling a former player to testify.

CJ Cron, who had two stints with the Angels, testified on Monday, Dec. 1, that Skaggs informed Cron he could acquire opioids from Angels communications employee Eric Kay, according to The Athletic. Cron testified he eventually paid cash to Kay and received the pills in the Angels clubhouse.

Kay is serving a 22-year sentence for providing Skaggs an oxycodone pill laced with fentanyl that resulted in the pitcher’s July 2019 death. Skaggs’ family is seeking $120 million in future earnings plus other damages from the Angels, claiming they knew or should have known that Kay was providing drugs to Skaggs.

Cron, a first baseman and designated hitter, testified that Skaggs informed him Kay could provide pills, likely after Cron mentioned he was playing through pain. Cron previously testified in a similar fashion at Kay’s criminal trial in Texas.

The Angels traded Cron to Tampa Bay before the 2018 season; according to The Athletic, Cron testified that Skaggs delivered him 15 oxycontin pills at Tampa Bay’s team hotel when the club played the Angels in May, and Cron paid Kay in cash later at Angel Stadium.

Cron also texted Skaggs in July 2018 before the Angels visited Tampa Bay.

‘Get as many blues from EK as you can, I’ll pay you however much.’

Replied Skaggs, in a reference to Kay’s struggles with addiction: ‘Lol he is off them. Text him.’

Cron testified that his text to Skaggs was in jest.

The Angels, per The Athletic, are scheduled to call orthopedist Neal ElAttrache, who performed Skaggs’ 2014 Tommy John surgery, and club president John Carpino to the witness stand this week. Skaggs’ mother, Debbie Hetman, testified that she informed ElAttrache of Skaggs’ 2013 Percocet addiction. The trial is scheduled to conclude Dec. 12.

This post appeared first on USA TODAY
0 comment
0
FacebookTwitterPinterestEmail

previous post
Inside Lane Kiffin’s villainous exit from Ole Miss, hero’s arrival at LSU
next post
PWHL home openers show league continues to grow

You may also like

Bills player sounds off on Sean McDermott firing:...

January 20, 2026

Bo Nix’s wife, Izzy, shares heart-wrenching, candid photo...

January 20, 2026

Lakers star Luka Doncic tops fan vote for...

January 20, 2026

Arizona leads as rest of men’s basketball poll...

January 20, 2026

Sarah Strong helps UConn women’s basketball snap skid...

January 20, 2026

10 most important players for Indiana-Miami in national...

January 20, 2026

Another NFL playoff team makes stunning change at...

January 19, 2026

Morocco star apologizes for disastrous penalty kick in...

January 19, 2026

Lions hire Drew Petzing as new offensive coordinator,...

January 19, 2026

UConn women’s basketball to play LSU in Nashville,...

January 19, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News And Articles.

    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    Top News

    Saks files for bankruptcy as luxury market struggles

    January 15, 2026

    Warner Bros. Discovery rejects Paramount’s amended takeover offer

    January 10, 2026

    Trump Media to merge with nuclear fusion company

    December 20, 2025

    Shopify says a daylong Cyber Monday outage has...

    December 3, 2025

    Prada Group says it has purchased fashion rival...

    December 3, 2025

    • About us
    • Contacts
    • Email Whitelisting
    • Privacy Policy
    • Terms and Conditions

    Copyright © 2025 MarketGainsUpdates.com All Rights Reserved.

    Market Gains Updates
    • Economy
    • Investing
    • Politics
    • Sports
    • Editor’s Pick